The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTILS.L Share News (TILS)

  • There is currently no data for TILS

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Tiziana Life Sciences Settles Fee; Director Zambeletti Departs

Wed, 20th Nov 2019 13:02

(Alliance News) - Tiziana Life Sciences PLC on Wednesday announced the departure of a director and the issue of shares in order to satisfy an GBP82,000 consultancy fee.

The London-headquartered biotechnology firm said Leopoldo Zambeletti has resigned as a non-executive officer.

"The company notes the significant business interests of Mr Zambeletti in a wide range of life sciences companies and expresses its gratitude for Mr Zambeletti's contribution to the company during his tenure," said Tiziana.

Further, the company has issued 190,698 shares at a price of 43 pence each to satisfy a GBP82,000 consultancy fee, without saying to whom it was paying the fee.

Following this, Tiziana will have 136.7 million shares in issue.

Shares in Tiziana were untraded at 41.00p in London on Wednesday during midday trading.

By Anna Farley; annafarley@alliancenews.com

Copyright 2019 Alliance News Limited. All Rights Reserved.

More News

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.